Dan Cohen, President and Cofounder of Adhere+
The COVID-19 pandemic catalyzed a rapid and necessary transformation in the delivery of healthcare services, especially for vulnerable populations with opioid use disorder (OUD). Regulatory flexibilities introduced during…
Continue Reading
Mark Matson, Senior Director, Sensor Cloud at Medidata
Clinical trials are the foundation of drug development, generating life-saving medicines for the betterment of society. But trials can be arduous, lengthy, and expensive for patients, sites,…
Continue Reading
Early prediction of disability progression in multiple sclerosis (MS) remains challenging despite its critical importance for therapeutic decision-making. We present the first systematic evaluation of personalized federated learning (PFL) for 2-year MS disability progression…
Continue Reading
Rameez Chatni, Global Director AI Solutions—Pharmaceutical and Life Sciences at Cloudera
As precision medicine continues to reshape the future of healthcare, clinical trials are evolving from one-size-fits-all studies into highly targeted investigations driven by genomics…
Continue Reading
Image Credit: b-rayZ
What You Should Know:
– Affidea, a pan-European provider of community-based polyclinics, specialist services, and advanced diagnostics, has announced a strategic collaboration with b-rayZ, a leader in AI-powered breast imaging solutions.
– The strategic…
Continue Reading
Background: In midlife, many women experience significant physical and psychological symptoms associated with perimenopause and menopause, impacting their well-being and quality of life. While behavioral interventions are effective in alleviating these symptoms, access can…
Continue Reading
Top News
UCSF professor and University of California Health System chief data scientist Atul Butte, MD, PhD died Friday. He was 55.
Butte held the Priscilla Chan and Mark Zuckerberg Distinguished Professorship of pediatrics, bioengineering…
What You Should Know:
– Serve You Rx announced today the inclusion of two newly approved biosimilars to Stelara® (ustekinumab) – Otulfi™ (ustekinumab-aauz) and Yesintek™ (ustekinumab-face) – to its Biosimilar Advantage Formulary. This move is…
Continue Reading
Clients have long used traditional tools such as journals, metaphor, movement and artwork to express what words alone could not capture. Today, immersive technologies offer new ways to explore and externalize the internal experience,…
Continue Reading
Deb Nevins, Chief Marketing & Strategy Officer at POCN Group
For decades, life sciences companies have centered their marketing efforts on physicians, assuming they hold the greatest influence over prescribing and treatment decisions. However, the…
Continue Reading
